{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:53:03Z","timestamp":1791327183883,"version":"4.3.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004742","name":"National Academy of Sciences of Ukraine","doi-asserted-by":"publisher","award":["0125U002921"],"award-info":[{"award-number":["0125U002921"]}],"id":[{"id":"10.13039\/501100004742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004742","name":"National Academy of Sciences of Ukraine","doi-asserted-by":"publisher","award":["0125U002921"],"award-info":[{"award-number":["0125U002921"]}],"id":[{"id":"10.13039\/501100004742","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61201-6","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:57:45Z","timestamp":1783411065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ketodarolutamide may interact with the receptor-binding domain of the SARS-CoV-2 spike glycoprotein: the importance of halogenated benzonitrile"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0186-1235","authenticated-orcid":false,"given":"Andrii","family":"Zaremba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7253-0404","authenticated-orcid":false,"given":"Polina","family":"Zaremba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0892-772X","authenticated-orcid":false,"given":"Sv\u0456tlana","family":"Zahorodnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"61201_CR1","unstructured":"World Health Organization. Available online: https:\/\/www.who.int\/europe\/emergencies\/situations\/covid-19."},{"key":"61201_CR2","doi-asserted-by":"publisher","first-page":"2632010X2312180","DOI":"10.1177\/2632010X231218075","volume":"16","author":"AK Dofuor","year":"2023","unstructured":"Dofuor, A. K. et al. The Global Impact of COVID-19: Historical Development, Molecular Characterization, Drug Discovery and Future Directions. Clin. Pathol. 16, 2632010X231218075. https:\/\/doi.org\/10.1177\/2632010X231218075 (2023).","journal-title":"Clin. Pathol."},{"key":"61201_CR3","unstructured":"World Health Organization Data. Available online: https:\/\/data.who.int\/dashboards\/covid19\/cases."},{"key":"61201_CR4","doi-asserted-by":"publisher","first-page":"588013","DOI":"10.3389\/fmed.2021.588013","volume":"8","author":"J Geng","year":"2021","unstructured":"Geng, J. et al. Chronic Diseases as a Predictor for Severity and Mortality of COVID-19: A Systematic Review With Cumulative Meta-Analysis. Front. Med. (Lausanne). 8, 588013. https:\/\/doi.org\/10.3389\/fmed.2021.588013 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"61201_CR5","doi-asserted-by":"publisher","unstructured":"Vemula, D., Jayasurya, P., Sushmitha, V., Kumar, Y. N. & Bhandari, V. C. A. D. D. AI and ML in drug discovery: A comprehensive review. Eur. J. Pharm. Sci. 2023, 181, 106324. https:\/\/doi.org\/10.1016\/j.ejps.2022.106324","DOI":"10.1016\/j.ejps.2022.106324"},{"key":"61201_CR6","doi-asserted-by":"publisher","unstructured":"Yadav, R. et al. Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells 10 (4), 821. https:\/\/doi.org\/10.3390\/cells10040821 (2021).","DOI":"10.3390\/cells10040821"},{"key":"61201_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.15407\/microbiolj84.01.034","volume":"84","author":"A Zaremba","year":"2021","unstructured":"Zaremba, A., Zaremba, P., Muchnyk, F. V., Baranova, G. & Zahorodnia, S. In Silico Identification of a Viral Surface Glycoprotein Site Suitable for the Development of Low Molecular Weight Inhibitors for Various Variants of the SARS-CoV-2. Mikrobiol. Z. 84, 34\u201343. https:\/\/doi.org\/10.15407\/microbiolj84.01.034 (2021).","journal-title":"Mikrobiol. Z."},{"key":"61201_CR8","doi-asserted-by":"publisher","unstructured":"Mannar, D. et al. SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein\u2013ACE2 complex. Science 375, 760\u2013764. https:\/\/doi.org\/10.1126\/science.abn7760.","DOI":"10.1126\/science.abn7760"},{"key":"61201_CR9","doi-asserted-by":"publisher","unstructured":"Abraham, M. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1 https:\/\/doi.org\/10.1016\/j.softx.2015.06.001 (2015).","DOI":"10.1016\/j.softx.2015.06.001"},{"issue":"11","key":"61201_CR10","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/bioinformatics\/bts186","volume":"28","author":"E Pihan","year":"2012","unstructured":"Pihan, E., Colliandre, L., Guichou, J. F. & Douguet, D. E. -Drug3D: 3D Structure Collections Dedicated to Drug Repurposing and Fragment-Based Drug Design. Bioinformatics 28 (11), 1540\u20131541. https:\/\/doi.org\/10.1093\/bioinformatics\/bts186 (2012).","journal-title":"Bioinformatics"},{"issue":"1","key":"61201_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"ONM Boyle","year":"2011","unstructured":"Boyle, O.N.M. et al. Open Babel: An Open Chemical Toolbox. J. Cheminform. 3 (1), 33. https:\/\/doi.org\/10.1186\/1758-2946-3-33 (2011).","journal-title":"J. Cheminform."},{"issue":"8","key":"61201_CR12","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F., Forli, S. & AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J. Chem. Inf. Model. 61 (8), 3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203 (2021).","journal-title":"J. Chem. Inf. Model."},{"issue":"25","key":"61201_CR13","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jcc.23354","volume":"34","author":"J Huang","year":"2013","unstructured":"Huang, J. & MacKerell, A. D. CHARMM36 All-Atom Additive Protein Force Field: Validation Based on Comparison to NMR Data. J. Comput. Chem. 34 (25), 2135\u20132145. https:\/\/doi.org\/10.1002\/jcc.23354 (2013).","journal-title":"J. Comput. Chem."},{"issue":"43","key":"61201_CR14","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark, P. & Nilsson, L. Structure and Dynamics of the TIP3P, SPC, and SPC\/E Water Models at 298 K. J. Phys. Chem. A. 105 (43), 9954\u20139960. https:\/\/doi.org\/10.1021\/jp003020w (2001).","journal-title":"J. Phys. Chem. A"},{"key":"61201_CR15","doi-asserted-by":"publisher","unstructured":"Bugnon, M. et al. A modern web-based tool for efficient small molecule parametrization. J. Chem. Inf. Model 63(21), 6469\u20136475. https:\/\/doi.org\/10.1021\/acs.jcim.3c01053 (2023).","DOI":"10.1021\/acs.jcim.3c01053"},{"key":"61201_CR16","doi-asserted-by":"publisher","unstructured":"Hess, B., Bekker, H., Berendsen, H. & Fraaije, J. L. I. N. C. S. A Linear Constraint Solver for Molecular Simulations. J. Comput. Chem. 18. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199709)18:123.0.CO;2-H (1998).","DOI":"10.1002\/(SICI)1096-987X(199709)18:123.0.CO;2-H"},{"key":"61201_CR17","doi-asserted-by":"publisher","first-page":"120116","DOI":"10.1016\/j.molliq.2022.120116","volume":"365","author":"Q Ke","year":"2022","unstructured":"Ke, Q., Gong, X., Liao, S., Duan, C. & Li, L. Effects of Thermostats\/Barostats on Physical Properties of Liquids by Molecular Dynamics Simulations. J. Mol. Liq. 365, 120116. https:\/\/doi.org\/10.1016\/j.molliq.2022.120116 (2022).","journal-title":"J. Mol. Liq."},{"issue":"10","key":"61201_CR18","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco, M. S., Vald\u00e9s-Tresanco, M. E., Valiente, P. A., & Moreno, E. gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS. J. Chem. Theory Comput. 17 (10), 6281\u20136291. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"61201_CR19","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1021\/jacs.6b02682","volume":"138","author":"L Duan","year":"2016","unstructured":"Duan, L., Liu, X. & Zhang, J. Z. H. Interaction Entropy: A New Paradigm for Highly Efficient and Reliable Computation of Protein\u2013Ligand Binding Free Energy. J. Am. Chem. Soc. 138, 5722\u20135728. https:\/\/doi.org\/10.1021\/jacs.6b02682 (2016).","journal-title":"J. Am. Chem. Soc."},{"issue":"42","key":"61201_CR20","doi-asserted-by":"publisher","first-page":"12263","DOI":"10.1021\/jp073399n","volume":"111","author":"C Tan","year":"2007","unstructured":"Tan, C., Tan, Y. H. & Luo, R. Implicit Nonpolar Solvent Models. J. Phys. Chem. B. 111 (42), 12263\u201312274. https:\/\/doi.org\/10.1021\/jp073399n (2007).","journal-title":"J. Phys. Chem. B"},{"issue":"5","key":"61201_CR21","first-page":"19","volume":"2","author":"P Turner","year":"2005","unstructured":"Turner, P. & XMGRACE Version 5.1.19. Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology, Beaverton. OR 2 (5), 19 (2005).","journal-title":"OR"},{"key":"61201_CR22","unstructured":"Dassault Syst\u00e8mes. Available online: https:\/\/discover.3ds.com\/discovery-studio-visualizer-download."},{"issue":"4","key":"61201_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski, C. A. Lead- and Drug-like Compounds: The Rule-of-Five Revolution. Drug Discov Today Technol. 1 (4), 337\u2013341. https:\/\/doi.org\/10.1016\/j.ddtec.2004.11.007 (2004).","journal-title":"Drug Discov Today Technol."},{"issue":"3","key":"61201_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jphs.2022.04.007","volume":"149","author":"Y Kato","year":"2022","unstructured":"Kato, Y. et al. Drug Repurposing for the Treatment of COVID-19. J. Pharmacol. Sci. 149 (3), 108\u2013114. https:\/\/doi.org\/10.1016\/j.jphs.2022.04.007 (2022).","journal-title":"J. Pharmacol. Sci."},{"key":"61201_CR25","doi-asserted-by":"publisher","first-page":"9389","DOI":"10.1080\/07391102.2022.2141886","volume":"41","author":"A Zaremba","year":"2023","unstructured":"Zaremba, A., Zaremba, P. & Zahorodnia, S. De novo designed inhibitor has high affinity to four variants of the RBD of S-glycoprotein of SARS-CoV-2 - an in silico study. J. Biomol. Struct. Dynamics. 41, 9389\u20139397. https:\/\/doi.org\/10.1080\/07391102.2022.2141886 (2023).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"61201_CR26","doi-asserted-by":"publisher","first-page":"11141","DOI":"10.1039\/D5CS00415B","volume":"54","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Li, Y., Chen, J. & Lai, L. Modeling protein\u2013ligand interactions for drug discovery in the era of deep learning. Chem. Soc. Rev. 54, 11141\u201311183. https:\/\/doi.org\/10.1039\/D5CS00415B (2025).","journal-title":"Chem. Soc. Rev."},{"key":"61201_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41598-017-18733-9","volume":"8","author":"A Kumar","year":"2018","unstructured":"Kumar, A., Kaur, H., Jain, A., Nair, D. T. & Salunke, D. M. Docking, thermodynamics and molecular dynamics (MD) studies of a non-canonical protease inhibitor, MP-4, from Mucuna pruriens. Sci. Rep. 8, 689. https:\/\/doi.org\/10.1038\/s41598-017-18733-9 (2018).","journal-title":"Sci. Rep."},{"issue":"24","key":"61201_CR28","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1021\/acs.biochem.8b00217","volume":"57","author":"D Herschlag","year":"2018","unstructured":"Herschlag, D. & M Pinney, M. Hydrogen Bonds: Simple after All? Biochemistry 57 (24), 3338\u20133352. https:\/\/doi.org\/10.1021\/acs.biochem.8b00217 (2018).","journal-title":"Biochemistry"},{"key":"61201_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","volume":"51","author":"T Hou","year":"2011","unstructured":"Hou, T., Wang, J., Li, Y. & Wang, W. Assessing the performance of the MM\/PBSA and MM\/GBSA methods: I. The accuracy of binding free energy calculations based on molecular dynamics simulations. J. Chem. Inf. Model. 51, 69\u201382. https:\/\/doi.org\/10.1021\/ci100275a (2011).","journal-title":"J. Chem. Inf. Model."},{"issue":"12","key":"61201_CR30","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/v14122728","volume":"14","author":"ES Giotis","year":"2022","unstructured":"Giotis, E. S., Cil, E. & Brooke, G. N. Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients. Viruses 14 (12), 2728. https:\/\/doi.org\/10.3390\/v14122728 (2022).","journal-title":"Viruses"},{"key":"61201_CR31","doi-asserted-by":"publisher","first-page":"774773","DOI":"10.3389\/fmed.2022.774773","volume":"9","author":"KM Lee","year":"2022","unstructured":"Lee, K. M. et al. Population-Level Analysis of the Protective Effects of Androgen Deprivation Therapy Against COVID-19 Disease Incidence and Severity. Front. Med. (Lausanne). 9, 774773. https:\/\/doi.org\/10.3389\/fmed.2022.774773 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"61201_CR32","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/cancers16020298","volume":"16","author":"M Cani","year":"2024","unstructured":"Cani, M. et al. Antiandrogens as Therapies for COVID-19: A Systematic Review. Cancers (Basel). 16, 298. https:\/\/doi.org\/10.3390\/cancers16020298 (2024).","journal-title":"Cancers (Basel)"},{"key":"61201_CR33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/cancers18020264","volume":"18","author":"O Caffo","year":"2026","unstructured":"Caffo, O. et al. Long-Term Oncological Outcomes in Metastatic Prostate Cancer Patients Who Are Able to Maintain\/Recover Ongoing Anticancer Therapy After SARS-CoV-2 Infection-Results of the MEET-URO 22 Study. Cancers (Basel). 18, 264. https:\/\/doi.org\/10.3390\/cancers18020264 (2026).","journal-title":"Cancers (Basel)"},{"key":"61201_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/0970-1591.52907","volume":"25","author":"A Bagrodia","year":"2009","unstructured":"Bagrodia, A., DiBlasio, C. J., Wake, R. W. & Derweesh, I. H. Adverse effects of androgen deprivation therapy in prostate cancer: Current management issues. Indian J. Urol. 25, 169\u2013176. https:\/\/doi.org\/10.4103\/0970-1591.52907 (2009).","journal-title":"Indian J. Urol."},{"key":"61201_CR35","doi-asserted-by":"publisher","first-page":"598","DOI":"10.5534\/wjmh.200092","volume":"39","author":"HH Lee","year":"2021","unstructured":"Lee, H. H., Park, S., Joung, J. Y. & Kim, S. H. How Does Androgen Deprivation Therapy Affect Mental Health including Cognitive Dysfunction in Patients with Prostate Cancer? World J. Mens Health. 39, 598\u2013605. https:\/\/doi.org\/10.5534\/wjmh.200092 (2021).","journal-title":"World J. Mens Health"},{"key":"61201_CR36","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1021\/acsinfecdis.1c00070","volume":"7","author":"D Bojadzic","year":"2021","unstructured":"Bojadzic, D. et al. Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2. ACS Infect. Dis. 7, 1519\u20131534. https:\/\/doi.org\/10.1021\/acsinfecdis.1c00070 (2021).","journal-title":"ACS Infect. Dis."},{"key":"61201_CR37","doi-asserted-by":"publisher","first-page":"e0143721","DOI":"10.1128\/JVI.01437-21","volume":"95","author":"A Acharya","year":"2021","unstructured":"Acharya, A. et al. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants. J. Virol. 95, e0143721. https:\/\/doi.org\/10.1128\/JVI.01437-21 (2021).","journal-title":"J. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61201-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:45:46Z","timestamp":1791326746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61201-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61201"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61201-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research does not involve living beings, so an Ethics statement is not required.","order":2,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31169"}}